Hexarelin Acetate is a synthetic hexapeptide that stimulates the release of growth hormone (GH) without interfering with the body's natural production of GH. Its structure is similar to that of GHRP-6 (LINK TO GHRP-6) but without causing an increase in appetite due to its inability to significantly increase Ghrelin levels, which is responsible for appetite stimulation and gastric emptying.
Hexarelin is a synthetic growth hormone secretagogue made up of six amino acids, which has been shown in studies to reduce visceral fat over time. Individuals using IGF-1 typically experience increased strength and muscle mass as well as significant fat loss.
Studies conducted on rats have shown that GHRP-6 has the potential to correct dyslipidemia while simultaneously reducing blood sugar and insulin resistance. This peptide could serve as an alternative to existing lipid medications for treating severe dyslipidemia. Furthermore, research indicates that Hexarelin not only protects the heart muscle but also regulates calcium flow and mitochondrial dysfunction.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Hexarelin is a synthetic growth hormone secretagogue peptide supplied for controlled laboratory research on growth hormone release, pituitary signaling, and cardiometabolic pathways. This research-grade hexapeptide is manufactured to tight specifications and validated by third-party analytical testing to support reproducible preclinical work.
Because of its strong receptor-level activity, Hexarelin is frequently used as a tool compound in studies exploring growth hormone axis behavior, endocrine signaling dynamics, and metabolic readouts across controlled models. Research teams expanding these protocols often also review Nordsci resources on weight-focused Hexarelin research frameworks, growth hormone secretagogue model design, and how peptide stacks are organized in preclinical studies when mapping broader endocrine research programs.
Hexarelin Research Peptide Specifications:
| Unit Size | 5 mg/vial |
| Unit Quantity | 1 vial |
| Purity (HPLC) | > 99% |
| Sequence | His–D-2-methyl-Trp–Ala–Trp–D-Phe–Lys–NH2 |
| Molecular Formula | C47H58N12O6 |
| Molecular Weight | 887.0 g/mol (approx.) |
| CAS Number | 140703-51-1 |
| Appearance | Lyophilized white to off-white powder |
| Source | Chemical synthesis |
| Storage Conditions | Store lyophilized Hexarelin at -20°C in a dry, dark environment. After reconstitution, store at 4°C and use within the recommended research holding period in accordance with institutional guidelines. |
| Research Use Only | This research peptide is intended for laboratory research use only. Not for human consumption, clinical use, or therapeutic applications. |
Hexarelin, also known as examorelin, is a synthetic hexapeptide growth hormone secretagogue that selectively binds to the growth hormone secretagogue receptor, part of the ghrelin receptor family. By engaging this receptor on pituitary somatotrophs and hypothalamic neurons, Hexarelin has been shown in preclinical and early clinical research to stimulate pulsatile growth hormone release.[1,2]
Unlike endogenous ghrelin, Hexarelin is structurally optimized for increased stability and potency at the receptor level. Laboratory investigations have evaluated Hexarelin as a model compound for dissecting growth hormone axis regulation, as well as for exploring downstream effects on metabolism, body composition, and cardiovascular signaling.[1–3]
Key research domains include:
That combination of endocrine and downstream tissue relevance makes Hexarelin useful in programs where researchers want a high-signal secretagogue model and need to isolate how upstream receptor activation affects multiple biological systems. Teams refining these workflows may also benefit from Nordsci’s educational content on secretagogue comparison strategy and stack sequencing and variable control.
Hexarelin has been investigated extensively for its capacity to stimulate growth hormone release via receptor activation. In preclinical studies and early human trials, Hexarelin has shown robust secretagogue effects, including enhanced amplitude and frequency of growth hormone pulses.[1,2] These responses have been evaluated in the context of age-related decline, hypothalamic–pituitary axis dysregulation, and pharmacologic stimulation testing.
Researchers use Hexarelin to map the dynamics of hormone release and feedback, compare secretagogue analogs and receptor-binding profiles, and characterize relationships between pulse behavior, downstream biomarkers, and tissue-level effects.
One of the most active areas of Hexarelin research involves its cardiometabolic and myocardial effects. In animal models of myocardial infarction, heart failure, and cardiotoxicity, Hexarelin has been studied for potential cardioprotective properties, including effects on left ventricular function, fibrosis, and apoptotic signaling.[3–5]
These investigations often focus on receptor expression in cardiac tissue, modulation of pro-survival pathways, anti-apoptotic signaling, and remodeling of ventricular geometry and contractility after injury. That makes Hexarelin especially relevant for labs running structured studies across endocrine and cardiovascular endpoints rather than purely metabolic models.
Because growth hormone plays a central role in musculoskeletal integrity, Hexarelin has been evaluated in models of bone density, muscle mass, and frailty. Preclinical work has examined how chronic or intermittent secretagogue stimulation may impact bone mineral content, trabecular architecture, and lean mass, particularly in the context of aging or glucocorticoid exposure.[2,4]
Laboratories also deploy Hexarelin in comparative datasets focused on growth hormone dependent versus growth hormone independent musculoskeletal effects, interactions with downstream anabolic signaling, and potential synergy with exercise or mechanical loading in experimental systems. For broader protocol context, Nordsci’s related material on body-composition model design can help support cleaner study architecture.
Although Hexarelin is not primarily framed as a weight-loss peptide in research, growth hormone axis modulation has implications for adiposity, lipid handling, and insulin sensitivity. Preclinical work has therefore incorporated Hexarelin into broader metabolic frameworks, including diet-induced obesity models and insulin-resistance paradigms.[3–5]
These studies leverage Hexarelin to better understand how growth hormone pulsatility, energy expenditure, and substrate utilization intersect, particularly when compared against other endocrine or metabolic research tools. This is where strong variable separation and lot-to-lot sourcing consistency become operationally important.
Important Research Notice: Nordsci peptides undergo independent third-party laboratory testing to verify purity and identity. Certificate of Analysis documentation is available for each research lot to support rigorous scientific methods and quality assurance.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
Nordsci provides batch-specific analytical documentation for Hexarelin, including HPLC chromatograms and mass spectrometry identity confirmation.
Download Hexarelin COA Lab Test Results
Research-grade Hexarelin should be sourced from suppliers capable of delivering high-purity peptide, validated identity, and transparent quality documentation. Nordsci specializes in research-only peptides and stacks that support rigorous preclinical design, with a focus on consistency across lots and clearly defined specifications.
How to Source Hexarelin for Laboratory Research
When evaluating suppliers, researchers should confirm that each lot of Hexarelin is accompanied by a Certificate of Analysis with analytical data, documented sequence and molecular characteristics, storage guidance, and a clear research-use-only designation aligned with non-clinical applications.
Hexarelin Research Peptide Pricing Considerations
Pricing for Hexarelin varies according to purity grade, quantity, and formulation strategy. Procurement teams should also budget for appropriate storage, handling, and any additional analytical confirmation required by institutional policy.
Research Institution Procurement and Compliance
Principal investigators and purchasing teams should ensure that Hexarelin acquisition aligns with internal purchasing policies, chemical inventory management systems, and safety documentation requirements. Proper labeling, secure storage, and controlled access are essential to support compliant, long-term research programs involving growth hormone secretagogues.
IMPORTANT: Hexarelin is sold exclusively for in vitro research and laboratory applications. It is not approved for human use, clinical protocols, or any therapeutic application. Researchers are responsible for adhering to all applicable regulations governing peptide research in their jurisdiction.
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
